IMTX Immatics NV

Shares of biopharmaceutical company Immatics (NASDAQ:IMTX) are rising today after the company announced an underwritten stock offering of $110 million. Immatics is offering ~10.9 million common shares at $10.09 apiece. The offer closes on October 12. Despite today’s gains, Immatics shares are still down 21.5% over the past month.
https://www.tipranks.com/news/immatics-rises-on-110m-underwritten-offering?utm_source=advfn.com&utm_medium=referral